Roche Holding Ag
-
{
- All
- News
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
- Monday September 6, 2021
- India News | Reuters
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
www.ndtv.com
-
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
- Wednesday March 4, 2020
- World News | Reuters
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
-
www.ndtv.com
-
Study Finds Targeted Cancer Drugs May Work In Range Of Tumor Types
- Sunday June 5, 2016
- Health | Reuters
Early results from a clinical trial of Roche Holding AG cancer drugs released on Saturday suggest some promise in matching treatments based on abnormalities found in a patient's tumor rather than the organ in which the cancer was originally detected.
-
www.ndtv.com
-
Hetero Gets Emergency Use Nod For Generic Version Of Covid Drug Tocilizumab
- Monday September 6, 2021
- India News | Reuters
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.
-
www.ndtv.com
-
China Approves Roche Arthritis Drug To Treat Some Coronavirus Patients
- Wednesday March 4, 2020
- World News | Reuters
China will use a Roche Holding AG arthritis drug to treat some coronavirus patients in severe conditions, health authorities said on Wednesday, as the country seeks to build up treatment regimens to help the infected recover.
-
www.ndtv.com
-
Study Finds Targeted Cancer Drugs May Work In Range Of Tumor Types
- Sunday June 5, 2016
- Health | Reuters
Early results from a clinical trial of Roche Holding AG cancer drugs released on Saturday suggest some promise in matching treatments based on abnormalities found in a patient's tumor rather than the organ in which the cancer was originally detected.
-
www.ndtv.com